Oestrogen receptor-negative (ER-) breast cancer is intrinsically sensitive to chemotherapy. However, tumour response is often incomplete, and relapse occurs with high frequency. The aim of this work was to analyse the molecular characteristics of residual tumours and early response to chemotherapy in patient-derived xenografts (PDXs) of breast cancer.

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

CAIRO, Stefano Enrico;
2015

Abstract

Oestrogen receptor-negative (ER-) breast cancer is intrinsically sensitive to chemotherapy. However, tumour response is often incomplete, and relapse occurs with high frequency. The aim of this work was to analyse the molecular characteristics of residual tumours and early response to chemotherapy in patient-derived xenografts (PDXs) of breast cancer.
2015
Legrier, Marie Emmanuelle; Bièche, Ivan; Gaston, Julie; Beurdeley, Arnaud; Yvonnet, Vanessa; Déas, Olivier; Thuleau, Aurélie; Château Joubert, Sophie; Servely, Jean Luc; Vacher, Sophie; Lassalle, Myriam; Depil, Stéphane; C. Tucker, Gordon; Fontaine, Jean Jacques; Poupon, Marie France; Roman Roman, Sergio; Judde, Jean Gabriel; Decaudin, Didier; Cairo, Stefano Enrico; Marangoni, Elisabetta
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2336025
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 58
social impact